_id
690dabfcccc777a4e85d0955
Ticker
AIDA
Name
Aida Pharmaceuticals Inc
Exchange
PINK
Address
31 Dingjiang Road, Hangzhou, China, 310016
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
-
Description
Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. It offers antibiotics, cardiovascular, and anti-cancer drugs. The company provides its products in the form of powder for injection; and liquid for intravenous injection, capsule, tablet, and ointment. The company provides Etimicin Sulfate, an injectable powder form, as well as rh-Apo2l, a biopharmaceutical therapy for cancers. Aida Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Hangzhou, China.
Last Close
0.0002
Volume
2000
Current Price
0.0003
Change
0
Last Updated
2026-01-20T14:59:39.499Z
Image
-
Ipo Date
-
Market Cap
12555000
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2008-09-30
Revenue
11885000
Cost Of Revenue
4958000
Gross Profit
6927000
Operating Expenses
4396000
Operating Income
2531000
Interest Expense
580765
Pretax Income
1939000
Net Income
2290000
Eps
0.08481481481481482
Dividends Per Share
0
Shares Outstanding
0
Income Tax Expense
-936000
EBITDA
3356000
Operating Margin
21.29575094657131
Total Other Income Expense Net
-592000
Cash
8278318
Short Term Investments
1699953
Receivables
12313324
Inventories
5465271
Total Current Assets
32282111
Property Plant Equipment
20789529
Total Assets
73987720
Payables
3013479
Short Term Debt
32553017
Long Term Debt
8606730
Total Liabilities
56648446
Equity
9157039
Bs_currency_symbol
USD
Depreciation
824894
Change In Working Capital
-587560
Cash From Operations
2148309
Capital Expenditures
2552297
Cash From Investing
-1818655
Cash From Financing
3753054
Net Change In Cash
4042842
Cf_currency_symbol
USD
PE
-
PB
0.0008845654146498666
ROE
25.008083945039438
ROA
3.09510821525518
FCF
-403988
Fcf Percent
-0.03399141775347076
Piotroski FScore
3
Health Score
49
Deep Value Investing Score
8
Defensive Investing Score
5.5
Dividend Investing Score
3.5
Economic Moat Investing Score
6.3
Garp Investing Score
3
Growth Investing Score
3
Momentum Investing Score
7
Net Net Investing Score
2
Quality Investing Score
6
Value Investing Score
8.5
Quarters > 0 > quarter
2008-09-30
Quarters > 0 > income Statement > revenue
11885000
Quarters > 0 > income Statement > cost Of Revenue
4958000
Quarters > 0 > income Statement > gross Profit
6927000
Quarters > 0 > income Statement > operating Expenses
4396000
Quarters > 0 > income Statement > operating Income
2531000
Quarters > 0 > income Statement > interest Expense
580765
Quarters > 0 > income Statement > pretax Income
1939000
Quarters > 0 > income Statement > net Income
2290000
Quarters > 0 > income Statement > eps
0.08481481481481482
Quarters > 0 > income Statement > dividends Per Share
0
Quarters > 0 > income Statement > shares Outstanding
27000000
Quarters > 0 > income Statement > income Tax Expense
-936000
Quarters > 0 > income Statement > EBITDA
3356000
Quarters > 0 > income Statement > operating Margin
21.29575094657131
Quarters > 0 > income Statement > total Other Income Expense Net
-592000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
8278318
Quarters > 0 > balance Sheet > short Term Investments
1699953
Quarters > 0 > balance Sheet > receivables
12313324
Quarters > 0 > balance Sheet > inventories
5465271
Quarters > 0 > balance Sheet > total Current Assets
32282111
Quarters > 0 > balance Sheet > property Plant Equipment
20789529
Quarters > 0 > balance Sheet > total Assets
73987720
Quarters > 0 > balance Sheet > payables
3013479
Quarters > 0 > balance Sheet > short Term Debt
32553017
Quarters > 0 > balance Sheet > long Term Debt
8606730
Quarters > 0 > balance Sheet > total Liabilities
56648446
Quarters > 0 > balance Sheet > equity
9157039
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
2211291
Quarters > 0 > cash Flow > depreciation
824894
Quarters > 0 > cash Flow > change In Working Capital
-587560
Quarters > 0 > cash Flow > cash From Operations
2148309
Quarters > 0 > cash Flow > capital Expenditures
2552297
Quarters > 0 > cash Flow > cash From Investing
-1818655
Quarters > 0 > cash Flow > cash From Financing
3753054
Quarters > 0 > cash Flow > net Change In Cash
4042842
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
0.08481481481481482
Quarters > 0 > ratios > PB
0.0008845654146498666
Quarters > 0 > ratios > ROE
25.008083945039438
Quarters > 0 > ratios > ROA
3.09510821525518
Quarters > 0 > ratios > FCF
-403988
Quarters > 0 > ratios > Piotroski FScore
3
Quarters > 0 > ratios > fcf Percent
-0.03399141775347076
Quarters > 0 > health Score
49
Quarters > 1 > quarter
2008-06-30
Quarters > 1 > income Statement > revenue
10900000
Quarters > 1 > income Statement > cost Of Revenue
4732000
Quarters > 1 > income Statement > gross Profit
6168000
Quarters > 1 > income Statement > operating Expenses
-306000
Quarters > 1 > income Statement > operating Income
6474000
Quarters > 1 > income Statement > interest Expense
737945
Quarters > 1 > income Statement > pretax Income
-7173000
Quarters > 1 > income Statement > net Income
-6771000
Quarters > 1 > income Statement > eps
-0.25077777777777777
Quarters > 1 > income Statement > dividends Per Share
0
Quarters > 1 > income Statement > shares Outstanding
27000000
Quarters > 1 > income Statement > income Tax Expense
-468000
Quarters > 1 > income Statement > EBITDA
-5791000
Quarters > 1 > income Statement > operating Margin
59.39449541284404
Quarters > 1 > income Statement > total Other Income Expense Net
-13647000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
4235476
Quarters > 1 > balance Sheet > short Term Investments
1690796
Quarters > 1 > balance Sheet > receivables
12250912
Quarters > 1 > balance Sheet > inventories
4497631
Quarters > 1 > balance Sheet > total Current Assets
26006853
Quarters > 1 > balance Sheet > property Plant Equipment
19196728
Quarters > 1 > balance Sheet > total Assets
66583173
Quarters > 1 > balance Sheet > payables
2744773
Quarters > 1 > balance Sheet > short Term Debt
29367486
Quarters > 1 > balance Sheet > long Term Debt
7309547
Quarters > 1 > balance Sheet > total Liabilities
52030073
Quarters > 1 > balance Sheet > equity
6261806
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-6777277
Quarters > 1 > cash Flow > depreciation
683048
Quarters > 1 > cash Flow > change In Working Capital
1217709
Quarters > 1 > cash Flow > cash From Operations
1524286
Quarters > 1 > cash Flow > capital Expenditures
767154
Quarters > 1 > cash Flow > cash From Investing
-258859
Quarters > 1 > cash Flow > cash From Financing
-921471
Quarters > 1 > cash Flow > net Change In Cash
-361466
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.25077777777777777
Quarters > 1 > ratios > PB
0.001293556523469427
Quarters > 1 > ratios > ROE
-108.13174346187027
Quarters > 1 > ratios > ROA
-10.169236002015104
Quarters > 1 > ratios > FCF
757132
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
0.0694616513761468
Quarters > 1 > health Score
22
Quarters > 2 > quarter
2008-03-31
Quarters > 2 > income Statement > revenue
7652000
Quarters > 2 > income Statement > cost Of Revenue
3700000
Quarters > 2 > income Statement > gross Profit
3952000
Quarters > 2 > income Statement > operating Expenses
3268000
Quarters > 2 > income Statement > operating Income
684202
Quarters > 2 > income Statement > interest Expense
545563
Quarters > 2 > income Statement > pretax Income
312940
Quarters > 2 > income Statement > net Income
-18980
Quarters > 2 > income Statement > eps
-0.000702962962962963
Quarters > 2 > income Statement > dividends Per Share
0
Quarters > 2 > income Statement > shares Outstanding
27000000
Quarters > 2 > income Statement > income Tax Expense
116149
Quarters > 2 > income Statement > EBITDA
1186000
Quarters > 2 > income Statement > operating Margin
8.94147935180345
Quarters > 2 > income Statement > total Other Income Expense Net
-371000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
4596942
Quarters > 2 > balance Sheet > short Term Investments
11291973
Quarters > 2 > balance Sheet > receivables
18687412
Quarters > 2 > balance Sheet > inventories
4413831
Quarters > 2 > balance Sheet > total Current Assets
41028857
Quarters > 2 > balance Sheet > property Plant Equipment
17867520
Quarters > 2 > balance Sheet > total Assets
68260996
Quarters > 2 > balance Sheet > payables
2507271
Quarters > 2 > balance Sheet > short Term Debt
30181717
Quarters > 2 > balance Sheet > long Term Debt
7219652
Quarters > 2 > balance Sheet > total Liabilities
46630653
Quarters > 2 > balance Sheet > equity
13222668
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-18980
Quarters > 2 > cash Flow > depreciation
501352
Quarters > 2 > cash Flow > change In Working Capital
67179
Quarters > 2 > cash Flow > cash From Operations
611425
Quarters > 2 > cash Flow > capital Expenditures
456639
Quarters > 2 > cash Flow > cash From Investing
-8783699
Quarters > 2 > cash Flow > cash From Financing
4863516
Quarters > 2 > cash Flow > net Change In Cash
-3802364
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.000702962962962963
Quarters > 2 > ratios > PB
0.000612584389171686
Quarters > 2 > ratios > ROE
-0.14354137909232842
Quarters > 2 > ratios > ROA
-0.02780504404008403
Quarters > 2 > ratios > FCF
154786
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
0.020228175640355464
Quarters > 2 > health Score
17
Quarters > 3 > quarter
2007-12-31
Quarters > 3 > income Statement > revenue
10517000
Quarters > 3 > income Statement > cost Of Revenue
4770000
Quarters > 3 > income Statement > gross Profit
5747000
Quarters > 3 > income Statement > operating Expenses
2487000
Quarters > 3 > income Statement > operating Income
3260000
Quarters > 3 > income Statement > interest Expense
841280
Quarters > 3 > income Statement > pretax Income
934288
Quarters > 3 > income Statement > net Income
2406000
Quarters > 3 > income Statement > eps
0.08911111111111111
Quarters > 3 > income Statement > dividends Per Share
0
Quarters > 3 > income Statement > shares Outstanding
27000000
Quarters > 3 > income Statement > income Tax Expense
168692
Quarters > 3 > income Statement > EBITDA
3722000
Quarters > 3 > income Statement > operating Margin
30.997432727964245
Quarters > 3 > income Statement > total Other Income Expense Net
-2325000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
8399306
Quarters > 3 > balance Sheet > short Term Investments
10553431
Quarters > 3 > balance Sheet > receivables
10831199
Quarters > 3 > balance Sheet > inventories
3837659
Quarters > 3 > balance Sheet > total Current Assets
36280846
Quarters > 3 > balance Sheet > property Plant Equipment
17022190
Quarters > 3 > balance Sheet > total Assets
62731171
Quarters > 3 > balance Sheet > payables
2547129
Quarters > 3 > balance Sheet > short Term Debt
31721106
Quarters > 3 > balance Sheet > long Term Debt
1647134
Quarters > 3 > balance Sheet > total Liabilities
41543319
Quarters > 3 > balance Sheet > equity
13316821
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
2406437
Quarters > 3 > cash Flow > depreciation
462570
Quarters > 3 > cash Flow > change In Working Capital
-2211634
Quarters > 3 > cash Flow > cash From Operations
1885100
Quarters > 3 > cash Flow > capital Expenditures
1481779
Quarters > 3 > cash Flow > cash From Investing
-3810665
Quarters > 3 > cash Flow > cash From Financing
1959939
Quarters > 3 > cash Flow > net Change In Cash
706006
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
0.08911111111111111
Quarters > 3 > ratios > PB
0.0006082532760634088
Quarters > 3 > ratios > ROE
18.067375088994588
Quarters > 3 > ratios > ROA
3.835413816840753
Quarters > 3 > ratios > FCF
403321
Quarters > 3 > ratios > Piotroski FScore
3
Quarters > 3 > ratios > fcf Percent
0.03834943424931064
Quarters > 3 > health Score
51
Annuals > 0 > quarter
2007-12-31
Annuals > 0 > income Statement > revenue
29204000
Annuals > 0 > income Statement > cost Of Revenue
14511000
Annuals > 0 > income Statement > gross Profit
14693000
Annuals > 0 > income Statement > operating Expenses
9248000
Annuals > 0 > income Statement > operating Income
5445000
Annuals > 0 > income Statement > interest Expense
2022000
Annuals > 0 > income Statement > pretax Income
2022000
Annuals > 0 > income Statement > net Income
2740000
Annuals > 0 > income Statement > eps
0.10148148148148148
Annuals > 0 > income Statement > dividends Per Share
0
Annuals > 0 > income Statement > shares Outstanding
27000000
Annuals > 0 > income Statement > income Tax Expense
360041
Annuals > 0 > income Statement > EBITDA
7320000
Annuals > 0 > income Statement > operating Margin
18.6447062046295
Annuals > 0 > income Statement > total Other Income Expense Net
-3423000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
8399306
Annuals > 0 > balance Sheet > short Term Investments
10553431
Annuals > 0 > balance Sheet > receivables
10831199
Annuals > 0 > balance Sheet > inventories
3837659
Annuals > 0 > balance Sheet > total Current Assets
36280846
Annuals > 0 > balance Sheet > property Plant Equipment
17022190
Annuals > 0 > balance Sheet > total Assets
62731171
Annuals > 0 > balance Sheet > payables
2547129
Annuals > 0 > balance Sheet > short Term Debt
31721106
Annuals > 0 > balance Sheet > long Term Debt
1647134
Annuals > 0 > balance Sheet > total Liabilities
41543319
Annuals > 0 > balance Sheet > equity
13316821
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
2739825
Annuals > 0 > cash Flow > depreciation
1874681
Annuals > 0 > cash Flow > change In Working Capital
2143641
Annuals > 0 > cash Flow > cash From Operations
8391633
Annuals > 0 > cash Flow > capital Expenditures
3613202
Annuals > 0 > cash Flow > cash From Investing
-11750736
Annuals > 0 > cash Flow > cash From Financing
5018435
Annuals > 0 > cash Flow > net Change In Cash
2282490
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
0.10148148148148148
Annuals > 0 > ratios > PB
0.0006082532760634088
Annuals > 0 > ratios > ROE
20.57548119029309
Annuals > 0 > ratios > ROA
4.367844496319063
Annuals > 0 > ratios > FCF
4778431
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.16362248322147652
Annuals > 0 > health Score
66
Annuals > 1 > quarter
2006-12-31
Annuals > 1 > income Statement > revenue
29643000
Annuals > 1 > income Statement > cost Of Revenue
14081000
Annuals > 1 > income Statement > gross Profit
15562000
Annuals > 1 > income Statement > operating Expenses
11626000
Annuals > 1 > income Statement > operating Income
3936000
Annuals > 1 > income Statement > interest Expense
1703000
Annuals > 1 > income Statement > pretax Income
2323000
Annuals > 1 > income Statement > net Income
1454000
Annuals > 1 > income Statement > eps
0.05602435171271144
Annuals > 1 > income Statement > dividends Per Share
0
Annuals > 1 > income Statement > shares Outstanding
25953000
Annuals > 1 > income Statement > income Tax Expense
173258
Annuals > 1 > income Statement > EBITDA
6016000
Annuals > 1 > income Statement > operating Margin
13.278008298755188
Annuals > 1 > income Statement > total Other Income Expense Net
-1614000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
6116816
Annuals > 1 > balance Sheet > short Term Investments
362758
Annuals > 1 > balance Sheet > receivables
16638499
Annuals > 1 > balance Sheet > inventories
2806945
Annuals > 1 > balance Sheet > total Current Assets
28627940
Annuals > 1 > balance Sheet > property Plant Equipment
14006041
Annuals > 1 > balance Sheet > total Assets
53810444
Annuals > 1 > balance Sheet > payables
3332174
Annuals > 1 > balance Sheet > short Term Debt
27659895
Annuals > 1 > balance Sheet > long Term Debt
5638314
Annuals > 1 > balance Sheet > total Liabilities
38280813
Annuals > 1 > balance Sheet > equity
10352218
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
1453584
Annuals > 1 > cash Flow > depreciation
2080040
Annuals > 1 > cash Flow > change In Working Capital
-2730600
Annuals > 1 > cash Flow > cash From Operations
2660457
Annuals > 1 > cash Flow > capital Expenditures
2968227
Annuals > 1 > cash Flow > cash From Investing
-4406361
Annuals > 1 > cash Flow > cash From Financing
4453405
Annuals > 1 > cash Flow > net Change In Cash
2987366
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
0.05602435171271144
Annuals > 1 > ratios > PB
0.0007520996949639197
Annuals > 1 > ratios > ROE
14.045299277893877
Annuals > 1 > ratios > ROA
2.7020776858856617
Annuals > 1 > ratios > FCF
-307770
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
-0.010382552373241575
Annuals > 1 > health Score
46
Annuals > 2 > quarter
2005-12-31
Annuals > 2 > income Statement > revenue
24527000
Annuals > 2 > income Statement > cost Of Revenue
8334000
Annuals > 2 > income Statement > gross Profit
16194000
Annuals > 2 > income Statement > operating Expenses
14074000
Annuals > 2 > income Statement > operating Income
2120000
Annuals > 2 > income Statement > interest Expense
1103000
Annuals > 2 > income Statement > pretax Income
1508000
Annuals > 2 > income Statement > net Income
1468000
Annuals > 2 > income Statement > eps
0.062515969678903
Annuals > 2 > income Statement > dividends Per Share
0
Annuals > 2 > income Statement > shares Outstanding
23482000
Annuals > 2 > income Statement > income Tax Expense
144720
Annuals > 2 > income Statement > EBITDA
3812000
Annuals > 2 > income Statement > operating Margin
8.643535695356139
Annuals > 2 > income Statement > total Other Income Expense Net
-612000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
3129450
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
13714491
Annuals > 2 > balance Sheet > inventories
3348592
Annuals > 2 > balance Sheet > total Current Assets
22412980
Annuals > 2 > balance Sheet > property Plant Equipment
12844348
Annuals > 2 > balance Sheet > total Assets
42659137
Annuals > 2 > balance Sheet > payables
1622449
Annuals > 2 > balance Sheet > short Term Debt
21450710
Annuals > 2 > balance Sheet > long Term Debt
3717380
Annuals > 2 > balance Sheet > total Liabilities
32369599
Annuals > 2 > balance Sheet > equity
6724107
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
1468335
Annuals > 2 > cash Flow > depreciation
1691527
Annuals > 2 > cash Flow > change In Working Capital
2367672
Annuals > 2 > cash Flow > cash From Operations
6120649
Annuals > 2 > cash Flow > capital Expenditures
700314
Annuals > 2 > cash Flow > cash From Investing
-4779965
Annuals > 2 > cash Flow > cash From Financing
-1165429
Annuals > 2 > cash Flow > net Change In Cash
319400
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
0.062515969678903
Annuals > 2 > ratios > PB
0.0010476632807895532
Annuals > 2 > ratios > ROE
21.831895298513246
Annuals > 2 > ratios > ROA
3.4412322968465117
Annuals > 2 > ratios > FCF
5420335
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.2209946181758878
Annuals > 2 > health Score
69
Annuals > 3 > quarter
2004-12-31
Annuals > 3 > income Statement > revenue
15645000
Annuals > 3 > income Statement > cost Of Revenue
4623000
Annuals > 3 > income Statement > gross Profit
11023000
Annuals > 3 > income Statement > operating Expenses
8167000
Annuals > 3 > income Statement > operating Income
2856000
Annuals > 3 > income Statement > interest Expense
481019
Annuals > 3 > income Statement > pretax Income
2535000
Annuals > 3 > income Statement > net Income
1635000
Annuals > 3 > income Statement > eps
0.0699435318275154
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
23376000
Annuals > 3 > income Statement > income Tax Expense
150997
Annuals > 3 > income Statement > EBITDA
3625000
Annuals > 3 > income Statement > operating Margin
18.25503355704698
Annuals > 3 > income Statement > total Other Income Expense Net
-321000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
2810050
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
7987160
Annuals > 3 > balance Sheet > inventories
2831877
Annuals > 3 > balance Sheet > total Current Assets
18283744
Annuals > 3 > balance Sheet > property Plant Equipment
3572845
Annuals > 3 > balance Sheet > total Assets
25246792
Annuals > 3 > balance Sheet > payables
847924
Annuals > 3 > balance Sheet > short Term Debt
0
Annuals > 3 > balance Sheet > long Term Debt
1087416
Annuals > 3 > balance Sheet > total Liabilities
18575948
Annuals > 3 > balance Sheet > equity
5111627
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
1634940
Annuals > 3 > cash Flow > depreciation
609338
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-2521628
Annuals > 3 > cash Flow > capital Expenditures
1164253
Annuals > 3 > cash Flow > cash From Investing
-2159407
Annuals > 3 > cash Flow > cash From Financing
4975568
Annuals > 3 > cash Flow > net Change In Cash
294557
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
0.0699435318275154
Annuals > 3 > ratios > PB
0.0013719310896511032
Annuals > 3 > ratios > ROE
31.985901944723278
Annuals > 3 > ratios > ROA
6.4760703062789124
Annuals > 3 > ratios > FCF
-3685881
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
-0.2355948226270374
Annuals > 3 > health Score
52
Valuation > metrics > PE
0.08481481481481482
Valuation > metrics > PB
0.0008845654146498666
Valuation > final Score
90
Valuation > verdict
99.5% Undervalued
Profitability > metrics > ROE
25.008083945039438
Profitability > metrics > ROA
7.09371205619112
Profitability > metrics > Net Margin
0.19267984854859066
Profitability > final Score
90
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
6.186327916698837
Risk > metrics > Interest Coverage
4.358044992380739
Risk > final Score
23
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.9076550864049132
Liquidity > metrics > Quick Ratio
0.753991621777979
Liquidity > final Score
48
Liquidity > verdict
Weak
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
90
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
86
Prev Risks > 0
41
Prev Risks > 1
11
Prev Risks > 2
22
Prev Liquidities > 0
43
Prev Liquidities > 1
81
Prev Liquidities > 2
74
Updated At
2026-01-20T21:21:15.740Z
Earnings History > 0 > period
2008-09-30
Earnings History > 0 > report Date
2008-09-30
Earnings History > 0 > date
2008-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
0.0848
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2008-06-30
Earnings History > 1 > report Date
2008-06-30
Earnings History > 1 > date
2008-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.2508
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2008-03-31
Earnings History > 2 > report Date
2008-03-31
Earnings History > 2 > date
2008-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.0007
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2007-12-31
Earnings History > 3 > report Date
2007-12-31
Earnings History > 3 > date
2007-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
0.0891
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2007-09-30
Earnings History > 4 > report Date
2007-09-30
Earnings History > 4 > date
2007-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
0.0192
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2007-06-30
Earnings History > 5 > report Date
2007-06-30
Earnings History > 5 > date
2007-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.0006
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2007-03-31
Earnings History > 6 > report Date
2007-03-31
Earnings History > 6 > date
2007-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0059
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2006-12-31
Earnings History > 7 > report Date
2006-12-31
Earnings History > 7 > date
2006-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0.01
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2006-09-30
Earnings History > 8 > report Date
2006-09-30
Earnings History > 8 > date
2006-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
0.0343
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2006-06-30
Earnings History > 9 > report Date
2006-06-30
Earnings History > 9 > date
2006-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
0.016
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2006-03-31
Earnings History > 10 > report Date
2006-03-31
Earnings History > 10 > date
2006-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
0.0006
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2005-12-31
Earnings History > 11 > report Date
2005-12-31
Earnings History > 11 > date
2005-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.0611
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2005-09-30
Earnings History > 12 > report Date
2005-09-30
Earnings History > 12 > date
2005-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.0092
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. It offers antibiotics, cardiovascular, and anti-cancer drugs. The company provides its products in the form of powder for injection; and liquid for intravenous injection, capsule, tablet, and ointment. The company provides Etimicin Sulfate, an injectable powder form, as well as rh-Apo2l, a biopharmaceutical therapy for cancers. Aida Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Hangzhou, China.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AWriter Aida Rivera Ford, pride of Davao City, dies short of 100th birthday MEXC
Read more →Showing 2 of 10
(Last Updated 2008-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Aida Pharmaceuticals Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2008-09-30
EPS Actual
0.0848
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2008-09-30)
(Last Updated 2008-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2008-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2008-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.